Skip to main content
OpenTrials
Completed

NCT Number: NCT04480398

Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

Coronavirus disease 2019 (Covid-19) has been declared global emergency with immediate safety, preventative and curative measures to control the spread of virus. Confirmed cases are treated with clinical management as they are diagnosed but so far, there is no effective treatment or vaccine yet for Covid-19.

With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear.

Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 Asymptomatic Condition Asymptomatic Diseases COVID-19 Coronaviridae Infections Coronavirus Infections Disease Attributes Infections Lung Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University

Jodhpur, Rajasthan, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 18
  • A person diagnosed with COVID-19
  • Asymptomatic at the time of admission

Exclusion criteria

  • Patients over 75 years
  • Taking antibiotics or antiretroviral for any reason
  • Mild to Moderate symptoms at the time of hospital admission

Treatment and study plan

Guduchi Ghan Vati

Drug

Guduchi Ghan Vati is an Ayuvedic classical preparation which is prepared from aqueous of extract of Tinospora cordifolia.

Other names: Giloy Ghan Vati

Primary outcomes

  1. Virologic clearance

    Time frame: 21 days

    Virologic clearance indicates the duration from the first Covid-19 positive result to the first Covid-19 negative result

Secondary outcomes

  1. Change in the number of patients going from asymptomatic to moderately disease

    Time frame: 10-days of hospital admission

    change in the number of patients going from asymptomatic to moderately disease

  2. Hospital Stay

    Time frame: 21 days

    Total duration of stay in hospital for complete recovery

  3. Clinically relevant adverse effects

    Time frame: 21-days

    Clinically relevant adverse effects of Guduchi Ghan Vati (Disability, Discomfort reported)

Sponsors and collaborators

Lead sponsor

Aarogyam UK

Other

Collaborators

  • Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University
  • Samta Ayurveda Prakoshtha, India

Registry information

Official study title

A Retrospective Study on Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 21, 2020
Registry last updated
Jul 22, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.